S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
Log in
NASDAQ:ARCT

Arcturus Therapeutics News Headlines

$55.14
+0.84 (+1.55 %)
(As of 02/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$53.32
Now: $55.14
$57.21
50-Day Range
$49.37
MA: $70.06
$86.92
52-Week Range
$8.51
Now: $55.14
$129.71
Volume690,204 shs
Average Volume1.68 million shs
Market Capitalization$1.35 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.01

Headlines

Arcturus Therapeutics (NASDAQ ARCT) News Headlines Today

Source:
SourceHeadline
Arcturus Therapeutics (NASDAQ:ARCT) Downgraded by B. Riley to SellArcturus Therapeutics (NASDAQ:ARCT) Downgraded by B. Riley to Sell
marketbeat.com - February 17 at 2:24 PM
Arcturus Therapeutics (NASDAQ:ARCT) Downgraded by Zacks Investment Research to SellArcturus Therapeutics (NASDAQ:ARCT) Downgraded by Zacks Investment Research to Sell
marketbeat.com - January 26 at 5:07 PM
Arcturus Therapeutics Holdings Breaks Below 200-Day Moving Average - Notable for ARCTArcturus Therapeutics Holdings Breaks Below 200-Day Moving Average - Notable for ARCT
nasdaq.com - February 23 at 3:15 PM
Earnings Preview: Arcturus Therapeutics (ARCT) Q4 Earnings Expected to DeclineEarnings Preview: Arcturus Therapeutics (ARCT) Q4 Earnings Expected to Decline
nasdaq.com - February 23 at 10:09 AM
Arcturus Therapeutics (NASDAQ:ARCT)  Shares Down 11% Arcturus Therapeutics (NASDAQ:ARCT) Shares Down 11%
americanbankingnews.com - February 22 at 10:00 PM
Arcturus Therapeutics to Report Fourth Quarter and Year-End 2020 Financial Results and Provide Corporate Update on March 1, 2021Arcturus Therapeutics to Report Fourth Quarter and Year-End 2020 Financial Results and Provide Corporate Update on March 1, 2021
finance.yahoo.com - February 19 at 8:52 AM
TransCode Therapeutics Announces Key AppointmentsTransCode Therapeutics Announces Key Appointments
businesswire.com - February 18 at 1:02 PM
Whats in the Cards for Arcturus (ARCT) This Earnings Season?What's in the Cards for Arcturus (ARCT) This Earnings Season?
nasdaq.com - February 17 at 2:44 PM
Arcturus Therapeutics (NASDAQ:ARCT) Downgraded by B. RileyArcturus Therapeutics (NASDAQ:ARCT) Downgraded by B. Riley
americanbankingnews.com - February 17 at 2:25 PM
Transthyretin Industry 2021 Demand, Market Trends, Regional Outlook, Top Manufacturers, Business Growth and Forecast to 2027 | Industry Research BizTransthyretin Industry 2021 Demand, Market Trends, Regional Outlook, Top Manufacturers, Business Growth and Forecast to 2027 | Industry Research Biz
marketwatch.com - February 15 at 8:36 AM
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Consensus Recommendation of "Hold" from BrokeragesArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Consensus Recommendation of "Hold" from Brokerages
americanbankingnews.com - February 13 at 8:49 AM
Arcturus Therapeutics (NASDAQ:ARCT)  Shares Down 6.7% Arcturus Therapeutics (NASDAQ:ARCT) Shares Down 6.7%
americanbankingnews.com - February 12 at 8:18 PM
Drugmakers Look for New Ways to Test Covid-19 VaccinesDrugmakers Look for New Ways to Test Covid-19 Vaccines
wsj.com - February 11 at 1:29 PM
Arcturus Therapeutics (NASDAQ:ARCT) Shares Up 7.1%Arcturus Therapeutics (NASDAQ:ARCT) Shares Up 7.1%
americanbankingnews.com - February 4 at 7:50 PM
 Brokerages Expect Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) to Post -$0.92 EPS Brokerages Expect Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) to Post -$0.92 EPS
americanbankingnews.com - February 3 at 12:16 AM
Is the Options Market Predicting a Spike in Arcturus Therapeutics (ARCT) Stock?Is the Options Market Predicting a Spike in Arcturus Therapeutics (ARCT) Stock?
finance.yahoo.com - January 28 at 1:27 PM
Is Arcturus Therapeutics a Buy?Is Arcturus Therapeutics a Buy?
finance.yahoo.com - January 12 at 9:50 AM
Why Arcturus Therapeutics Stock Skyrocketed TodayWhy Arcturus Therapeutics Stock Skyrocketed Today
finance.yahoo.com - January 7 at 6:24 PM
Biotech Stock Roundup: MRNAs COVID-19 Vaccine Updates & Other Pipeline UpdatesBiotech Stock Roundup: MRNA's COVID-19 Vaccine Updates & Other Pipeline Updates
finance.yahoo.com - January 6 at 12:20 PM
Arcturus (ARCT) to Begin Phase II COVID-19 Vaccine StudyArcturus (ARCT) to Begin Phase II COVID-19 Vaccine Study
finance.yahoo.com - January 5 at 11:17 AM
Outlook for biotech companies in 2021Outlook for biotech companies in 2021
finance.yahoo.com - January 4 at 12:39 PM
Arcturus Therapeutics Receives FDA Allowance to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate in the United StatesArcturus Therapeutics Receives FDA Allowance to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate in the United States
finance.yahoo.com - January 4 at 7:39 AM
Arcturus gets FDA go-ahead to begin Phase 2 trial for COVID-19 vaccine candidateArcturus gets FDA go-ahead to begin Phase 2 trial for COVID-19 vaccine candidate
finance.yahoo.com - January 4 at 7:39 AM
Time to Go Bargain Hunting on Arcturus Stock? Analyst Weighs InTime to Go Bargain Hunting on Arcturus Stock? Analyst Weighs In
finance.yahoo.com - December 31 at 10:44 PM
Arcturus (ARCT) Shares Fall on COVID-19 Vaccine Study ResultsArcturus' (ARCT) Shares Fall on COVID-19 Vaccine Study Results
nasdaq.com - December 30 at 2:40 PM
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Analysts Just Slashed Next Years Revenue Estimates By 49%Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Analysts Just Slashed Next Year's Revenue Estimates By 49%
nasdaq.com - December 30 at 9:40 AM
Markets Ease Lower as Arcturus, Blink Charging PlungeMarkets Ease Lower as Arcturus, Blink Charging Plunge
finance.yahoo.com - December 29 at 5:52 PM
Novavax Starts a Phase 3 Trial for Its Covid Vaccine, While Arcturus Gets 5 Downgrades for Its StockNovavax Starts a Phase 3 Trial for Its Covid Vaccine, While Arcturus Gets 5 Downgrades for Its Stock
barrons.com - December 29 at 12:46 PM
Lemonade Stock Gains, Arcturus Therapeutics Tumbles as Stock Market Rally ContinuesLemonade Stock Gains, Arcturus Therapeutics Tumbles as Stock Market Rally Continues
barrons.com - December 29 at 12:46 PM
Return On Capital Employed Overview: Arcturus TherapeuticsReturn On Capital Employed Overview: Arcturus Therapeutics
benzinga.com - December 29 at 12:46 PM
Stock Alert: Arcturus Therapeutics Tanks Over 50%Stock Alert: Arcturus Therapeutics Tanks Over 50%
nasdaq.com - December 29 at 12:46 PM
Why Analysts Lost Confidence in the Arcturus COVID-19 VaccineWhy Analysts Lost Confidence in the Arcturus COVID-19 Vaccine
msn.com - December 29 at 12:46 PM
Arcturus Slumps Amid Analyst Pessimism on VaccineArcturus Slumps Amid Analyst Pessimism on Vaccine
thestreet.com - December 29 at 12:46 PM
Arcturus Therapeutics shares slide 55% after COVID vaccine data are deemed ‘underwhelming’Arcturus Therapeutics shares slide 55% after COVID vaccine data are deemed ‘underwhelming’
marketwatch.com - December 29 at 12:46 PM
Apple, Quanterix, Arcturus: What to Watch When the Stock Market Opens TodayApple, Quanterix, Arcturus: What to Watch When the Stock Market Opens Today
wsj.com - December 29 at 7:46 AM
Arcturus Gets Approval For Covid-19 Vaccine Phase 2 Study; Shares Plunge 38%Arcturus Gets Approval For Covid-19 Vaccine Phase 2 Study; Shares Plunge 38%
nasdaq.com - December 29 at 7:46 AM
Arcturus Therapeutics Received Approval from Singapore Health Sciences Authority to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate and Provides New and Updated Clinical and Preclinical DataArcturus Therapeutics Received Approval from Singapore Health Sciences Authority to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate and Provides New and Updated Clinical and Preclinical Data
finance.yahoo.com - December 28 at 7:20 PM
Why Arcturus Therapeutics Stock Is Sinking TodayWhy Arcturus Therapeutics Stock Is Sinking Today
finance.yahoo.com - December 23 at 3:29 PM
3 Incomparable Coronavirus Vaccine Stocks to Buy Right Now3 Incomparable Coronavirus Vaccine Stocks to Buy Right Now
finance.yahoo.com - December 20 at 7:40 AM
Is ARCT A Good Stock To Buy?Is ARCT A Good Stock To Buy?
finance.yahoo.com - December 20 at 12:58 AM
Philippines can secure up to to 25 million doses of Moderna, Arcturus vaccines —envoy to USPhilippines can secure up to to 25 million doses of Moderna, Arcturus vaccines —envoy to US
msn.com - December 18 at 8:47 AM
UPDATE 1-Philippines can secure up to 25 mln doses of Moderna, Arcturus vaccines-ambassadorUPDATE 1-Philippines can secure up to 25 mln doses of Moderna, Arcturus vaccines-ambassador
reuters.com - December 18 at 8:47 AM
Philippines can secure up to 25 million doses of Moderna, Arcturus vaccines-ambassadorPhilippines can secure up to 25 million doses of Moderna, Arcturus vaccines-ambassador
reuters.com - December 18 at 12:19 AM
3 Top Coronavirus Stocks to Buy in December3 Top Coronavirus Stocks to Buy in December
finance.yahoo.com - December 13 at 7:23 AM
Why You Might Want to Buy This Potentially Game-Changing COVID Vaccine Stock Right NowWhy You Might Want to Buy This Potentially Game-Changing COVID Vaccine Stock Right Now
finance.yahoo.com - December 10 at 6:24 AM
Thinking about trading options or stock in Arcturus Therapeutics, Boeing, Advanced Micro Devices, Omnicell, or Carnival Corp?Thinking about trading options or stock in Arcturus Therapeutics, Boeing, Advanced Micro Devices, Omnicell, or Carnival Corp?
prnewswire.com - December 9 at 3:23 PM
Arcturus Therapeutics Announces Proposed Public Offering Of Common Stock; Size, Price Not DisclosedArcturus Therapeutics Announces Proposed Public Offering Of Common Stock; Size, Price Not Disclosed
benzinga.com - December 8 at 7:15 AM
Rainbows and Unicorns: Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Analysts Just Became A Lot More OptimisticRainbows and Unicorns: Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Analysts Just Became A Lot More Optimistic
nasdaq.com - December 8 at 7:15 AM
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common StockArcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
finance.yahoo.com - December 8 at 2:14 AM
Arcturus Therapeutics Announces Initiation of Dosing ARCT-810 in Patients with Ornithine Transcarbamylase (OTC) DeficiencyArcturus Therapeutics Announces Initiation of Dosing ARCT-810 in Patients with Ornithine Transcarbamylase (OTC) Deficiency
finance.yahoo.com - December 7 at 9:06 AM
Arcturus Therapeutics to Present at Upcoming Investor ConferenceArcturus Therapeutics to Present at Upcoming Investor Conference
finance.yahoo.com - November 30 at 6:30 PM
Arcturus Therapeutics shares are trading higher after the company on Tuesday reported Q3 results.Arcturus Therapeutics shares are trading higher after the company on Tuesday reported Q3 results.
benzinga.com - November 13 at 8:37 AM
This page was last updated on 2/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.